Academic literature on the topic 'IgM'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'IgM.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "IgM"

1

Avet-Loiseau, Hervé, Richard Garand, Laurence Lodé, Jean-Luc Harousseau, and Régis Bataille. "Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants." Blood 101, no. 4 (February 15, 2003): 1570–71. http://dx.doi.org/10.1182/blood-2002-08-2436.

Full text
Abstract:
In an attempt to address the issue of cytogenetic features of multiple myeloma (MM) variants, we have analyzed a series of 8 IgM, 9 IgD, 2 IgE, and 14 nonsecretory (NS) MM cases using fluorescence in situ hybridization. A very high incidence (83%) of t(11;14)(q13;q32) was detected in the IgM (7 of 8), IgE (2 of 2), and NS (11 of 14) MM cases, but not in the IgD cases (2 of 9). Of note, no t(4;14) was observed in this cohort of patients. This increased incidence of t(11;14) was associated with 2 dominant features in these variants, namely, a “lymphoplasmacytic” presentation mainly in IgM MM and a lower secreting capacity in the others, 2 features previously associated with t(11;14). Of major interest, t(11;14) was never observed in Waldenström macroglobulinemia or in IgG/IgA “lymphoplasmacytic” lymphomas. Thus, for unknown reasons, t(11;14) is the hallmark of IgM, IgE, and NS MM, (but not IgD MM), with a 5-fold increase of its incidence compared to that of IgG and IgA MM.
APA, Harvard, Vancouver, ISO, and other styles
2

Kolopp-Sarda, M. N., and G. C. Faure. "Pourquoi les immunoglobulines s’appellent-elles IgG, IgA, IgM, IgD et IgE ?" Revue Francophone des Laboratoires 2016, no. 484 (July 2016): 57–58. http://dx.doi.org/10.1016/s1773-035x(16)30250-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sharma, R., and Z. Woldehiwet. "Class-specific antibodies to bovine respiratory syncytial virus in experimentally infected lambs." Epidemiology and Infection 108, no. 1 (February 1992): 135–45. http://dx.doi.org/10.1017/s095026880004958x.

Full text
Abstract:
SUMMARYEnzyme-linked immunoabsorbent assay (ELISA) was used to titrate virus-specific IgG, IgM and IgA levels in nasal secretions, lung lavage fluids and serum samples sequentially obtained from lambs experimentally infected with bovine respiratory syncytial virus (RSV). Virus-specific IgG and IgM responses were measured by the indirect double antibody sandwich ELISA using anti-bovine RSV monoclonal antibody, as capture antibody, and peroxidase-conjugated anti-sheep IgG and anti-sheep IgM. Virus-specific IgA antibodies were measured by antibody capture assay using anti-sheep IgA (α–chain specific) and anti-bovine RSV monoclonal antibodies.Bovine RSV-specific IgM and IgA antibodies were detected in the serum samples within 6 days post-inoculation (p.i.). Virus-specific IgC antibodies appeared in serum samples 4 days later. In nasal secretions, IgA antibodies appeared 7 days p.i. but IgM antibodies were not detected until 12–16 days p.i. In serum samples, IgM titres were predominant for the first 2 weeks p.i. IgC titres becoming predominant thereafter. In nasal secretions and lung lavage fluids, IgA titres were significantly higher than IgM or IgG titres up to 21 days p.i. (0·01).
APA, Harvard, Vancouver, ISO, and other styles
4

Singh, Desh D., L. K. Dwivedi, Sarika Amdekar, and Vinod Singh. "The Immunoglobulin profiling of Schistosoma mansoni infected patients from Central India." South Asian Journal of Experimental Biology 1, no. 5 (December 6, 2011): 32–35. http://dx.doi.org/10.38150/sajeb.1(5).p32-35.

Full text
Abstract:
Schistosoma mansoni ‐schistosomicimmune response in them. Also, an attempt was made to correlate the observedIg level with the brutality of infection. Consequently, total 138(46.9%) out of 294 volunteers were reported to have ova of Schistosomamansoni in their urine samples. Among which, 84 (28.6%) volunteers with<50 ova in per 10 ml of urine showed light infection while remaining 54(18.4%) volunteers with >50 ova in per 10 ml of urine showed heavy infection.This difference was found statistically significant (X 2= 6.52, p > 0.05).The mean immunoglobulin status observed in their serum sample were; IgE(2141.6 ± 143.7 mg/dL), IgG (13.6 ± 3.53 mg/dL), IgA (3.72 ± 0.149 mg/dL),IgM (2.82 ± 0.48 mg/dL) and IgD (0.12 ± 0.04 mg/dL). The relationship betweenintensity of infection and serum level of IgM & IgE were positivelycorrelated (r =0.27 and r =0.65, respectively) while IgG, IgA and IgD wereshowing negative correlation with the strength of infection (r = ‐0.65, r = ‐0.39 and r = ‐0.18, respectively). Therefore, IgG and IgA can be considered asmarkers of light infection and IgM and IgE for heavy infection respectively.Since, the levels of IgG, IgA and IgD were found very low in infected volunteersthan control subjects hence, are suggested to play insignificant protectiverole in schistosomic infection., a trematode is a significant parasite of human beingscausing intestinal schistosomiasis. In the present investigation, 294 volunteersfrom central India were screened for schistosomic infection, and theserum immunoglobulin (Ig) levels were calculated as an anti
APA, Harvard, Vancouver, ISO, and other styles
5

Harfi, Harb A., and John T. Godwin. "Normal Serum Levels of IgG, IgA, IgM, IgD, and IgE in Saudi Arabia." Annals of Saudi Medicine 5, no. 2 (April 1985): 99–104. http://dx.doi.org/10.5144/0256-4947.1985.99.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Salonen, Eeva-Marjatta, Tapani Hovi, Olli Meurman, Timo Vesikari, and Antti Vaheri. "Kinetics of specific IgA, IgD, IgE, IgG, and IgM antibody responses in rubella." Journal of Medical Virology 16, no. 1 (May 1985): 1–9. http://dx.doi.org/10.1002/jmv.1890160102.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Collin, Mattias, and Arne Olsén. "Effect of SpeB and EndoS from Streptococcus pyogenes on Human Immunoglobulins." Infection and Immunity 69, no. 11 (November 1, 2001): 7187–89. http://dx.doi.org/10.1128/iai.69.11.7187-7189.2001.

Full text
Abstract:
ABSTRACT Streptococcus pyogenes secretes a specific immunoglobulin G (IgG)-protease, SpeB, as well as the IgG glycan-hydrolyzing enzyme EndoS. Here we show that SpeB also degrades IgA, IgM, IgD, and IgE. We also show that EndoS only hydrolyzes the glycan moiety on native but not denatured IgG. Thus, SpeB has a broad immunoglobulin-degrading activity, while EndoS is highly specific for IgG.
APA, Harvard, Vancouver, ISO, and other styles
8

Creasey, Alison M., Trine Staalsoe, Ahmed Raza, David E. Arnot, and J. Alexandra Rowe. "Nonspecific Immunoglobulin M Binding and Chondroitin Sulfate A Binding Are Linked Phenotypes of Plasmodium falciparum Isolates Implicated in Malaria during Pregnancy." Infection and Immunity 71, no. 8 (August 2003): 4767–71. http://dx.doi.org/10.1128/iai.71.8.4767-4771.2003.

Full text
Abstract:
ABSTRACT Binding of immunoglobulin M (IgM) antibodies from normal human serum to the surface of Plasmodium falciparum-infected red blood cells (iRBC) has previously been demonstrated only in parasites that form rosettes with uninfected red cells. We show that natural, nonspecific IgM but not IgG, IgA, IgD, or IgE also binds to the surface of iRBC selected for adhesion to chondroitin sulfate A (CSA), a placental receptor for parasites associated with malaria in pregnancy. The protease sensitivity of IgM-binding appears to match that of CSA binding, suggesting that the two phenotypes may be mediated by the same parasite molecule. We also show that a wide range of mouse monoclonal antibodies of the IgM class bind nonspecifically to CSA-selected iRBC, an important consideration in the interpretation of immunological assays performed on these parasite lines.
APA, Harvard, Vancouver, ISO, and other styles
9

Anam, Khairul, Farhat Afrin, Dwijadas Banerjee, Netai Pramanik, Subhasis K. Guha, Rama P. Goswami, Shiben K. Saha, and Nahid Ali. "Differential Decline in Leishmania Membrane Antigen-Specific Immunoglobulin G (IgG), IgM, IgE, and IgG Subclass Antibodies in Indian Kala-Azar Patients after Chemotherapy." Infection and Immunity 67, no. 12 (December 1, 1999): 6663–69. http://dx.doi.org/10.1128/iai.67.12.6663-6669.1999.

Full text
Abstract:
ABSTRACT Pathogenesis in kala-azar is associated with depressed cellular immunity and significant elevation of antileishmanial antibodies. Since these antibodies are present even after cure, analysis of the parasite-specific isotypes and immunoglobulin G (IgG) subclasses in kala-azar patients may shed new light on the immune responses during progression and resolution of infection. Using leishmanial membrane antigenic extracts, we investigated the relative levels of specific IgG, IgM, IgA, IgE, and IgG subclasses in Indian kala-azar patient sera during disease, drug resistance, and cure. Acute-phase sera showed strong stimulation of IgG, followed by IgE and IgM and lastly by IgA antibodies. IgG subclass analysis revealed expression of all of the subclasses, with a predominance of IgG1 during disease. Following sodium stibogluconate (SAG) resistance, the levels of IgG, IgM, IgE, and IgG4 remained constant, while there was a decrease in the titers of IgG2 and IgG3. In contrast, a significant (2.2-fold) increase in IgG1 was observed in these individuals. Cure, in both SAG-responsive and unresponsive patients, correlated with a decline in the levels of IgG, IgM, IgE, and all of the IgG subclasses. The stimulation of IgG1 and the persistence, most importantly, of IgE and IgG4 following drug resistance, along with a decline in IgE, IgG4, and IgG1 with cure, demonstrate the potential of these isotypes as possible markers for monitoring effective treatment in kala-azar.
APA, Harvard, Vancouver, ISO, and other styles
10

Fadnis, Madhura P., and Pratibha B. Shamkuwar. "A case of primary immunodeficiency: hyper IgM syndrome." International Journal of Contemporary Pediatrics 6, no. 6 (October 21, 2019): 2700. http://dx.doi.org/10.18203/2349-3291.ijcp20194758.

Full text
Abstract:
Hyper IgM syndrome are group to disorders characterized by elevated serum level of IgM and low or absent serum levels of IgG, IgA and IgE the mechanism of HIGM is immunoglobulin Class-Switch Recombination (CSR) failure and Somatic Hyper Mutation (SHM). This diagnosis should be considered in any patient presenting with hypogammaglobulinemia, with low or absent IgG and IgA and normal or elevated IgM level. In the present case report, this was a 6-year-old male child who had history of recurrent respiratory tract infections who presented with otitis media and persistent fever spikes. Immunoglobulin studies revealed a pattern consistent with hyper IgM.
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "IgM"

1

Suzuki, Lisandra Akemi. "Resposta imune humoral na neurocisticercose." [s.n.], 2010. http://repositorio.unicamp.br/jspui/handle/REPOSIP/308741.

Full text
Abstract:
Orientador: Claudio Lucio Rossi
Tese (doutorado) - Universidade Estadual de Campinas. Faculdade de Ciencias Medicas
Made available in DSpace on 2018-08-15T09:51:57Z (GMT). No. of bitstreams: 1 Suzuki_LisandraAkemi_D.pdf: 1217880 bytes, checksum: 4ceb1f773f112c88145bc69e02976ef2 (MD5) Previous issue date: 2010
Resumo: A neurocisticercose (NC) e uma importante causa de doença neurológica em muitos paises em desenvolvimento, incluindo o Brasil. O diagnostico clinico da NC e dificultado pelo polimorfismo e pela não especificidade dos sintomas. As tecnicas de neuroimagem e pesquisa de anticorpos específicos tem contribuído para o diagnostico da NC e uma melhor compreensão dos processos fisiopatológicos dessa infecção. O presente trabalho teve como objetivo avaliar, por meio de técnicas imunoenzimaticas (ELISA), a resposta imune humoral na NC, utilizando como preparações antigênicas o liquido vesicular (LV) e uma fração glicoproteica obtida do extrato bruto de cisticercos de Taenia solium (T. solium) com afinidade por lentil-lectina (fração Gp). Cinquenta e seis amostras de liquido cefalorraquidiano (LCR), 22 de pacientes com NC e 34 de pacientes com outros problemas neurológicos, foram utilizadas para a pesquisa de IgG e suas subclasses, com os seguintes resultados: IgG-LV: 100% de sensibilidade e especificidade; IgG1 -LV: 72,73% de sensibilidade e 100% de especificidade; IgG2-LV: 81,81% de sensibilidade e 100% de especificidade; IgG3-LV: 59,09% de sensibilidade e 97,06% de especificidade; IgG4-LV: 90,91% de sensibilidade e 97,06% de especificidade; IgG-fração Gp: 90,91% de sensibilidade e 97,06% de especificidade; IgG1-fração Gp: 59,09% de sensibilidade e 91,18% de especificidade; IgG2-fração Gp: 68,18% de sensibilidade e 94,12% de especificidade; IgG3-fração Gp: 36,36% de sensibilidade e 100% de especificidade; IgG4-fração Gp: 86,36% de sensibilidade e 100% de especificidade. Quarenta e sete amostras de LCR, 16 de pacientes com NC e 31 de pacientes com outros problemas neurológicos foram utilizadas para a pesquisa de IgE, com os seguintes resultados: IgE-LV e IgE-fração Gp: 93,75% de sensibilidade e 100% de especificidade. Cinquenta e sete amostras de soros, 22 de pacientes com NC, 18 de pacientes com outras infecções e 17 de pessoas presumivelmente sadias, foram utilizadas para a pesquisa da IgG e suas subclasses, IgE, IgA e IgM, com os seguintes resultados: IgG-LV: 100% de sensibilidade e especificidade; IgG1-LV: 86,36% de sensibilidade e 94,28% de especificidade; IgG2-LV: 90,91% de sensibilidade e 97,14% de especificidade; IgG3-LV: 86,36% de sensibilidade e 97,14% de especificidade; IgG4-LV: 100% de sensibilidade e de especificidade; IgG-fração Gp: 95,45% de sensibilidade e 100% de especificidade; IgG1-fração Gp: 63,64% de sensibilidade e 94,28% de especificidade; IgG2-fração Gp: 68,18% de sensibilidade e 97,14% de especificidade; IgG3-fração Gp: 54,54% de sensibilidade e 88,57% de especificidade; IgG4-fração Gp: 90,91% de sensibilidade e 100% de especificidade; IgELV: 90,91% de sensibilidade e 97,14% de especificidade; IgE-fração Gp: 86,36% de sensibilidade e 100% de especificidade; IgA-LV: 54,54% de sensibilidade e 94,28% de especificidade; IgA-fração Gp: 13,63% de sensibilidade e 100% de especificidade. Anticorpos IgM não foram detectados com as preparações de LV e fração Gp. Nossos resultados mostraram que, com ambas as preparações antigênicas, tanto em amostras de LCR quanto em amostras de soros, a maior positividade foi obtida na detecção de anticorpos das classes IgG e IgE, seguida da positividade da IgA. Anticorpos IgM não foram detectados em amostras de soros com reações de ELISA realizadas com LV e fração Gp. Com relação as subclasses da IgG, a IgG4 apresentou, tanto em amostras de LCR como em amostras de soros, valores de positividade e concentração iguais ou superiores as outras subclasses. As reações ELISA realizadas com LV mostraram sensibilidades iguais ou superiores aquelas obtidas com a fração Gp. Considerando a complexidade e o custo final da obtenção da fração Gp, o LV pode ser considerado mais adequado para a pesquisa de anticorpos em amostras de LCR e soros de pacientes com NC.
Abstract: Neurocysticercosis (NC) is an important cause of neurological disease in many developing countries, including Brazil. The clinical diagnosis of NC is hindered by the polymorphism and non-specificity of the symptoms. Neuroimaging techniques and detection of specific antibodies have contributed to the diagnosis of NC and a better understanding of the physiopathological processes of this infection. The purpose of this study was to evaluate the humoral immune response in NC by using immunoenzymatic techniques (ELISA) in which vesicular fluid (VF) and a glycoprotein fraction purified from a crude extract of Taenia solium cysticerci with affinity for lentil-lectin (fraction Gp) were used as antigenic preparations. Fifty-six cerebrospinal fluid (CSF) samples, 22 from patients with NC and 34 from patients with other neurological disorders, were assayed for IgG and IgG subclasses, with the following results: IgG-VF: 100% sensitivity and specificity, IgG1 - VF: 72.73% sensitivity and 100% specificity, IgG2 -VF: 81.81% sensitivity and 100% specificity, IgG3 -VF: 59.09% sensitivity and 97.06% specificity, IgG4 -VF: 90.91% sensitivity and 97.06% specificity, IgG-fraction Gp: 90.91% sensitivity and 97.06% specificity, IgG1- fraction Gp: 59.09% sensitivity and 91.18% specificity, IgG2-fraction Gp: 68.18% sensitivity and 94.12% specificity, IgG3 -fraction Gp: 36.36% sensitivity and 100% specificity, IgG4 - fraction Gp: 86.36% sensitivity and 100% specificity. Forty-seven CSF samples, 16 from patients with NC and 31 from patients with other neurological disorders, were assayed for IgE, with the following results: IgE-VF and IgE-fraction Gp: 93.75% sensitivity and 100% specificity. Fifty-seven serum samples, 22 from patients with NC, 18 from patients with other infections and 17 from presumably healthy individuals, were assayed for IgG, IgG subclasses, IgE, IgA and IgM, with the following results: IgG-VF: 100% sensitivity and specificity, IgG1-VF: 86.36% sensitivity and 94.28% specificity, IgG2 -VF: 90.91% sensitivity and 97.14% specificity, IgG3 -VF: 86.36% sensitivity and 97.14% specificity, IgG4 -VF:100% sensitivity and specificity, IgG-fraction Gp: 95.45% sensitivity and 100% specificity, IgG1- fraction Gp: 63.64% sensitivity and 94.28% specificity, IgG2 -fraction Gp: 68.18% sensitivity and 97.14% specificity, IgG3 -fraction Gp: 54.54% sensitivity and 88.57% specificity, IgG4 - fraction Gp: 90.91% sensitivity and 100% specificity, IgE-VF: 90.91% sensitivity and 97.14% specificity, IgE-fraction Gp: 86.36% sensitivity and 100% specificity, IgA-VF: 54.54% sensitivity and 94.28% specificity, IgA-fraction Gp: 13.63% sensitivity and 100% specificity. No specific IgM antibodies were detected with VF and fraction Gp antigenic preparations. These results show that with the two antigenic preparations the highest positivity in CSF and serum samples was obtained for IgG and IgE antibodies, followed by positivity for IgA. No IgM antibodies were detected in serum samples assayed with VF and fraction Gp. With regard to IgG subclasses, IgG4 positivity and concentration in CSF and serum samples were higher than or equal to the other subclasses. ELISA reactions done with VF showed equal or higher sensitivities than those obtained with fraction Gp. Considering the complexity and high cost of obtaining fraction Gp, VF could be more suitable for detecting specific antibodies in CSF and serum samples from patients with NC.
Doutorado
Ciencias Biomedicas
Doutor em Ciências Médicas
APA, Harvard, Vancouver, ISO, and other styles
2

Sellers, Lisa K. "Exercise-induced alterations in immunoglobulin (IgA, IgG, IgM) levels in cancer versus non-cancer patients." Muncie, Ind. : Ball State University, 2008. http://cardinalscholar.bsu.edu/384.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Renault, Neil. "Construction, method development and comparative testing of an 'All-Diet' protein microarray to measure IgA, IgM, IgG and IgE in human sera and milk." Thesis, University of Nottingham, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.503929.

Full text
Abstract:
Existing immunoglobulin (Ig) tests only give a limited picture of the immunological response to food antigens. Furthermore, existing tests require large volumes of sample, over a limited number of foods, are not amenable to a high sample through-put system and the results are limited to normally just one immunoglobulin class. In order to investigate the global immune response towards food products we have developed the "all diet" microarray concept. The "all-diet food protein microarray contains extracts of over 400 food ingredients that cover most of the food products found in the UK. Using this system we have retrospectively determined food specific IgE, IgA, IgG and IgM from 17 well characterized sera. The results were analyzed by multivariate techniques and parametric methods. The proof-of-concept of the ''all diet microarray to investigate the relationships between food antigen specificity and multiple Ig type was demonstrated here. The novelity of this protein microarray is the use of arrayed food samples sequentially extracted with detergent and chaotropic agents. The array system possesses many advantages over traditional systems such as requirement of low sample volume, high sensitivity and a global view of the immune response. Notwithstanding these potential advantages to clinical practices, these benefits remain yet to be demonstrated. The development of the technique will allow further expansion into areas of research such as conjugation of the microarray with sensitized human basophils and also immunoglobulin binding to extracts of parasites.
APA, Harvard, Vancouver, ISO, and other styles
4

Ding, Zhoujie. "Feedback Enhancement of Immune Responses by IgE, IgM, and IgG3 Antibodies." Doctoral thesis, Uppsala universitet, Institutionen för medicinsk biokemi och mikrobiologi, 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-237337.

Full text
Abstract:
Antibodies can enhance or suppress the immune responses against their specific antigens. This phenomenon is known as antibody-mediated feedback regulation. We have studied the mechanisms underlying IgE-, IgM-, and IgG3-mediated enhancement of immune responses in mouse models using intravenous immunization. We attempted to answer the following questions: 1) Which cell type presents IgE-complexed antigens to CD4+ T cells? 2) Is complement activation required for specific IgM to enhance antibody responses? 3) Does IgM enhance CD4+ T-cell responses? 4) How are IgG3-antigen complexes transported into B-cell follicles? We found that CD23+ B cells transporting IgE-antigen complexes into B-cell follicles were not required to prime the antigen-specific CD4+ T cells in vivo, whereas CD11c+ cells were indispensable. After examining the three most common subpopulations of CD11c+ cells in the spleen, we determined that it was CD8α- conventional dendritic cells migrating into the T-cell zone following immunization that presented IgE-complexed antigens to CD4+ T cells. Next, we showed that specific IgM from Cµ13 mice, which is unable to activate complement, failed to enhance either antibody or germinal center responses whereas wild-type IgM enhanced both responses. Therefore, specific IgM must activate complement to enhance humoral responses. In addition, wild-type IgM did not up-regulate CD4+ T-cell responses. Finally, we showed that IgG3-antigen complexes were transported by marginal zone B cells into B-cell follicles via binding to complement receptors 1 and 2 (CR1/2) on those cells. The immune complexes were captured by follicular dendritic cells as early as 2 h after immunization. Germinal center responses were also enhanced by IgG3. Using bone marrow chimeric mice, we found that CR1/2 expression was required on both marginal zone B cells and follicular dendritic cells to provide an optimal enhancement of antibody responses.
APA, Harvard, Vancouver, ISO, and other styles
5

Nascimento, Fernanda Santos. "Diagnostico sorologico da toxoplasmose." [s.n.], 2008. http://repositorio.unicamp.br/jspui/handle/REPOSIP/308746.

Full text
Abstract:
Orientador: Claudio Lucio Rossi
Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas
Made available in DSpace on 2018-08-10T14:37:04Z (GMT). No. of bitstreams: 1 Nascimento_FernandaSantos_M.pdf: 1195114 bytes, checksum: 8f7292945661258264c33482af428d55 (MD5) Previous issue date: 2008
Resumo: A toxoplasmose, uma zoonose com ampla distribuição mundial, causada pelo parasita intracelular obrigatório Toxoplasma gondii, é geralmente adquirida por meio da ingestão de cistos ou oocistos viáveis do parasita, presentes, respectivamente, em carne crua ou mal cozida e no solo, alimento ou água contaminados com fezes de gatos infectados. A toxoplasmose pode ser altamente debilitante, e ocasionalmente fatal, em crianças infectadas no útero e em receptores de transplante. O diagnóstico de infecção aguda primária em mulheres grávidas é geralmente baseado em testes sorológicos, visto que, na grande maioria dos casos, a toxoplasmose não é reconhecida clinicamente. A longa persistência dos anticorpos IgM em algumas pessoas e a dificuldade para demonstrar soroconversão ou aumento significativo da concentração de anticorpos específicos, têm complicado a interpretação dos testes sorológicos, quando se suspeita de infecção aguda. Com relação à infecção toxoplámica em pacientes transplantados, em muitos casos o status sorológico do doador não é conhecido e a pesquisa periódica de anticorpos anti-T. gondii no receptor raramente é realizada. O objetivo do primeiro estudo foi determinar o valor da demonstração dos anticorpos IgA anti-T.gondii para o diagnóstico da fase aguda da infecção toxoplásmica. Nossos resultados mostraram que os anticorpos IgA são detectados com alta freqüência em amostras de soros obtidas de mulheres com evidência clínica e/ou sorológica de infecção toxoplásmica aguda. Entretanto, em 19% das mulheres apresentando persistência de anticorpos IgM e alto índice de avidez dos anticorpos IgG, anticorpos IgA anti-T. gondii foram detectados em amostras de soros coletadas mais de 9 meses após o início da infecção, indicando que esses anticorpos não podem ser considerados marcadores confiáveis de infecção aguda primária. No segundo estudo, nós relatamos o diagnóstico de infecção toxoplásmica primária em um paciente com mieloma múltiplo submetido a transplante alogênico não-mieloablativo de células hematopoiéticas, provenientes de doador com sorologia negativa para toxoplasmose. A resposta primária contra o T. gondii foi baseada na soroconversão dos anticorpos IgM, IgG e IgA. O paciente foi prontamente tratado e nenhuma complicação relacionada à toxoplasmose foi observada nos meses subseqüentes. Esse caso ressalta a necessidade da detecção dos anticorpos anti-T. gondii no doador e no receptor antes do transplante e a importância do monitoramento sorológico do receptor durante o seguimento pós-transplante
Abstract: Toxoplasmosis, a cosmopolitan zoonotic disease caused by the intracellular parasite Toxoplasma gondii, is usually acquired through the ingestion of viable parasite cysts or oocysts, present, respectively, in raw or undercooked meat and in soil, food or water contaminated with feces of infected cats. Toxoplasmosis can be highly debilitating and occasionally fatal in children infected in utero and in transplant recipients. The diagnosis of acute primary infection in pregnant women is usually based on serology, because in the great majority of cases primary infection is not recognized clinically. The sustained persistence, in some persons, of specific IgM antibodies and the difficulty in demonstrating seroconversion or a significant increase in specific antibody concentrations, have complicated the interpretation of serological tests when acute infection is suspected. With regard to toxoplasmic infection in transplant patients, in many cases the serological status of the donor is not known and the periodic research of anti-T. gondii antibodies in the receptor is rarely performed. In the first study, we investigated the usefulness of detecting anti-T. gondii IgA for the diagnosis of an acute acquired Toxoplasma infection. Our results showed that anti-T. gondii IgA antibodies are detected with a high frequency in serum samples obtained from women with clinical and/or serologic evidence of acute acquired Toxoplasma infection. However, in 19% of the women presenting a sustained IgM antibody response and a high IgG avidity index, anti-T. gondii IgA antibodies were detected in serum samples collected more than nine months after the beginning of infection, indicating that IgA cannot be considered a dependable marker for acute primary infection. In the second study, we report the diagnosis of a primary toxoplasmic infection in a patient with multiple myeloma following a non-myeloablative allogeneic transplant with hematopoietic stem cells from a donor with negative serology for toxoplasmosis. The primary response to T. gondii was supported by IgM, IgG and IgA seroconversion. The patient was promptly treated and there were no complications related to toxoplasmosis in the subsequent months. This case stresses the importance of detecting anti-T. gondii antibodies in the donor and in the recipient before transplantation, and of serologically monitoring the recipient during long-term follow-u
Mestrado
Ciencias Biomedicas
Mestre em Ciências Médicas
APA, Harvard, Vancouver, ISO, and other styles
6

Keiserman, Briele. "Isotipos IgG e IgM anti-dsDNA em pacientes com lúpus eritematoso sistêmico." Pontifícia Universidade Católica do Rio Grande do Sul, 2012. http://hdl.handle.net/10923/4374.

Full text
Abstract:
Made available in DSpace on 2013-08-07T19:04:01Z (GMT). No. of bitstreams: 1 000438287-Texto+Completo-0.pdf: 659033 bytes, checksum: 74536bb270173b92a486ff2c17575495 (MD5) Previous issue date: 2012
IgG anti-dsDNA antibodies are associated to lupus nephritis. Recent data suggest that IgM isotype is nephroprotector. We evaluated the frequency of IgG anti-dsDNA in patients with Systemic lupus erythemathosus (SLE) and its relation between IgG/IgM proportion and clinical manifestations of the disease. This transversal study included 137 SLE patients according to traditional criteria (92. 5% female, 79. 5% Caucasian) and 58 SLE individual (93. 1% female, 81% Caucasian) selected by positivity for IgG anti-dsDNA. IgG and IgM anti-dsDNA antibodies were detected by Chrithidiae luciliae indirect immunofluorescence with cut point 1/10 dilution. The presence of IgG anti-dsDNA was associated to the presence of hemolytic anemia, leukopenia/lymphopenia and Complement depletion (p<0. 001). Of the 58 patients positive for IgG anti-dsDNA 15 were also positive for IgM anti-dsDNA. The group presenting both isotypes showed significant less frequency of active urinary sediment when compared to isolated IgG anti-dsDNA (6. 7% versus 34. 9%, p=0. 046). IgG/IgM proportion distribution evidenced a trend of higher medians in the presence of arthritis and leukopenia/lymphopenia [4 (2-8) versus 1 (1-2), p=0. 070 and 4 (3-8) versus 1 (1-4), p=0. 066, respectively]. Summarizing, the frequency of IG anti-dsDNA was relevant in our casuistic. Positive subpopulation for both IgG/IgM isotypes anti-dsDNA was less willing to urinary sediment alterations than IgG anti-dsDNA isolated population. These data suggest a distinct biologic behavior for IgM anti-dsDNA.
Anticorpos IgG anti-dsDNA se associam à ocorrência de nefrite lúpica. Relatos recentes sugerem que o isotipo IgM anti-dsDNA seja nefroprotetor. Avaliamos frequência de IgG anti-dsDNA em pacientes com lúpus eritematoso sistêmico (LES), e averiguamos a relação entre proporção IgG/IgM anti-dsDNA e manifestações clínicas da doença. O estudo, transversal, incluiu 137 pacientes com LES de acordo com os critérios tradicionais (92,5% mulheres, 79,5% raça branca) e uma população de 58 casos de LES (93,1% mulheres, 81% raça branca) selecionados por positividade para IgG anti-dsDNA. Anticorpos IgG e IgM anti-dsDNA foram detectados por imunofluorescência indireta com Crithidia luciliae, com ponto de corte na diluição 1/10. A presença de IgG anti-dsDNA se associou à presença de anemia hemolítica, leucolinfopenia e depleção de Complemento (p<0, 001). Dos 58 pacientes com teste positivo para IgG anti-dsDNA, 15 foram também positivos para o isotipo IgM. O grupo com ambos os isotipos teve frequência significativamente menor de sedimento urinário ativo quando comparado ao grupo com IgG anti-dsDNA isolado (6,7% versus 34,9%, p=0, 046). A distribuição da proporção IgG/IgM anti-dsDNA evidenciou tendência de medianas mais elevadas na presença de artrite e leucolinfopenia [4 (2-8) versus 1 (1-2), p=0, 070 e 4 (3-8) versus 1 (1-4), p=0, 066, respectivamente]. Em suma, a frequência de IgG anti-dsDNA foi relevante em nossa casuística. A subpopulação positiva para ambos IgG e IgM anti-dsDNA foi menos propensa a alterações de sedimento urinário do que aquela com IgG anti-dsDNA isolado. Estes dados sugerem um comportamento biológico distinto para o isotipo IgM anti-dsDNA.
APA, Harvard, Vancouver, ISO, and other styles
7

RODRIGUES, Isolina Maria Xavier. "Diagnóstico pós-natal da toxoplasmose congênita através da detecção de anticorpos das classes IgG, IgM E IgA ANTI-Toxoplasma gondii." Universidade Federal de Goiás, 2006. http://repositorio.bc.ufg.br/tede/handle/tde/1832.

Full text
Abstract:
Made available in DSpace on 2014-07-29T15:30:42Z (GMT). No. of bitstreams: 1 isolina.pdf: 450784 bytes, checksum: c6721c6f52877717341c489e21cf2261 (MD5) Previous issue date: 2006-03-31
Essa dissertação é composta de duas pesquisas complementares, realizadas no período de primeiro de janeiro de 2004 a 30 de setembro de 2005. No primeiro estudo, realizou-se a sorologia para IgG e IgM anti-toxoplasma no sangue do cordão de 1514 RN pela técnica MEIA e a comparação entre os resultados dos anticorpos IgG e IgM no sangue de cordão e periférico de 167 RN (86 suspeitos e 81 normais). A sorologia por MEIA permitiu que fossem selecionados 86 RN suspeitos de toxoplasmose congênita, cujas amostras foram testadas para detecção de IgM pela técnica ELFA. A comparação entre a sorologia para IgG e IgM por MEIA mostrou não haver diferença significativa entre os resultados obtidos no sangue de cordão e periférico. A triagem sorológica dos 1514 RN pela técnica MEIA revelou que: 0,59% (09/1514) apresentavam IgG e IgM reagentes; 64,60 (978/1514) apresentavam IgG reagente e IgM não reagente; 0,46% (7/1514) apresentavam IgG indeterminada e IgM não reagente e 34,35% (520/1514) apresentaram IgG e IgM não reagentes. A incidência da toxoplasmose diagnosticada pela presença de IgM pelas técnicas MEIA e ELFA foi de 6,6/1000 nascimentos, contudo essa incidência não reflete o número de RN infectados, pois muitos RN não produzem anticorpos de classe IgM ao nascer, sendo necessário que os 76 RN suspeitos e que tiveram IgM não reagentes sejam acompanhados até dois anos de idade. O segundo estudo foi realizado nas crianças suspeitas de toxoplasmose congênita acompanhadas no Ambulatório de Infecções Congênitas do HC. Das 86 encaminhadas para acompanhamento, apenas 56 retornaram para consulta. As amostras dessas crianças foram testadas para IgM anti T.gondii pelas técnicas MEIA, ELFA e IFI e para IgA por ELISA captura. O diagnóstico da infecção congênita foi concluído em 44 RN, sendo que 28 estavam infectados e 16 não estavam. Dos 28 infectados, 42,9% (12/28) apresentaram IgM reagente pelas técnicas usadas. A sensibilidade, 84 especificidade, acurácia, valores preditivos positivo e negativo das técnicas MEIA e ELFA foram iguais, respectivamente de 36,7%, 100%, 100%, 47,1% e 59,1%; da IFI 28,6%, 87,5%, 80,0%, 44,4% e 50% e da IgA de 25,0%, 100%, 100%, 43,2% e 52,3%. A IgM foi reagente em 81,8% (9/11) das crianças sintomáticas, demonstrando sua relação com a gravidade da transmissão vertical, com maiores concentrações em crianças mais afetadas pelo processo infeccioso intra-uterino. Por outro lado, não foi detectada em 57,1% (16/28) dos infectados, provavelmente em conseqüência do tratamento da mãe. A sensibilidade da IgM anti T.gondii, associando três técnicas (MEIA, ELFA e IFI) foi de 42,9% (12/28) e da IgA foi de 25% (7/28), mostrando que a suspeita de toxoplasmose congênita não pode ser afastada apenas pela ausência desses anticorpos.
APA, Harvard, Vancouver, ISO, and other styles
8

Chen, Frieda Huey. "A study of the IgM interaction with complement using mouse IgM/IgG2b domain-switched hybrids." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp02/NQ35123.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

BESIERS, CHRISTOPHE. "Alveolites allergiques extrinseques (poumon d'eleveurs d'oiseaux et poumon du fermier) : criteres diagnostiques et interet des isotypes specifiques igg, igm et iga." Reims, 1994. http://www.theses.fr/1994REIMM027.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Garyfalos, Anargyros. "IGM : Intelligent gateway multicast for MIPv6." Thesis, Lancaster University, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.525327.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "IgM"

1

Rosenberg, Jessica L., and Mary E. Putman, eds. The IGM/Galaxy Connection. Dordrecht: Springer Netherlands, 2003. http://dx.doi.org/10.1007/978-94-010-0115-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Università degli studi di Roma "La Sapienza", ed. Sambuchi: IGM 259 IV SE. Firenze: L. S. Olschki, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Tartara, Patrizia. Torrimpietra: IGM 149 I NO. [Florence, Italy]: L.S. Olschki, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Università degli studi di Roma "La Sapienza", ed. Aprilia: IGM F 158 IV NE. Roma: Università La Sapienza, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kubagawa, Hiromi, and Peter D. Burrows, eds. IgM and Its Receptors and Binding Proteins. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-64526-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Giulio, Sabbatini, ed. Venusia (IGM 187 I NO/I NE). [Firenze]: L.S. Olschki editore, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Valenti, Massimiliano. Ager Tusculanus: (IGM 150 III NE-II NO). Firenze: L.S. Olschki, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

K, Amin Soebandrio W. Diagnostik cepat Dengue: Deteksi IgM anti Dengue : laporan penelitian. [Jakarta]: Bagian Mikrobiologi, Fakultas Kedokteran, Universitas Indonesia, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ager Foronovanus I: IGM 138 III SO / 144 IV NO. Firenze: L.S. Olschki, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Rosenberg, Jessica L. The IGM/Galaxy Connection: The Distribution of Baryons at z=0. Dordrecht: Springer Netherlands, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "IgM"

1

Poslussny, P., K. Vinzenz, and F. Zekert. "Serumimmunglobuline (IgA, IgE, IgG, IgM) bei Patienten mit Kopf-Halskarzinomen." In Chirurgische Therapie von Kopf-Hals-Karzinomen, 335–42. Vienna: Springer Vienna, 1992. http://dx.doi.org/10.1007/978-3-7091-9087-6_39.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gooch, Jan W. "IgM." In Encyclopedic Dictionary of Polymers, 900. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-6247-8_13978.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Cabanne, Charlotte, and Xavier Santarelli. "PURIFICATION OF IgM and IgA." In Process Scale Purification of Antibodies, 615–29. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2017. http://dx.doi.org/10.1002/9781119126942.ch28.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kleine, T. O. "IgM-Index." In Lexikon der Medizinischen Laboratoriumsdiagnostik, 1. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-49054-9_1514-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Baum, H. "IgM-Paraprotein." In Lexikon der Medizinischen Laboratoriumsdiagnostik, 1. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-49054-9_1515-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kleine, T. O. "IgM-Index." In Springer Reference Medizin, 1192. Berlin, Heidelberg: Springer Berlin Heidelberg, 2019. http://dx.doi.org/10.1007/978-3-662-48986-4_1514.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Baum, H. "IgM-Paraprotein." In Springer Reference Medizin, 1192. Berlin, Heidelberg: Springer Berlin Heidelberg, 2019. http://dx.doi.org/10.1007/978-3-662-48986-4_1515.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Gertz, Morie A., Taimur Sher, Angela Dispenzieri, and Francis K. Buadi. "IgM Amyloidosis." In Waldenström’s Macroglobulinemia, 195–207. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-22584-5_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Lobo, Peter I. "Role of Natural IgM Autoantibodies (IgM-NAA) and IgM Anti-Leukocyte Antibodies (IgM-ALA) in Regulating Inflammation." In Current Topics in Microbiology and Immunology, 89–117. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/82_2017_37.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Schuster, Steven R., and Joseph Mikhael. "IgM Multiple Myeloma." In Multiple Myeloma, 283–87. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-8520-9_23.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "IgM"

1

Chekanova, T. A. "LABORATORY CONFIRMATION OF THE SPOTTED FEVER GROUP RICKETTSIOSES AMONG PATIENTS WITH TYPICAL AND ATYPICAL CLINICAL MANIFESTATIONS." In Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-81.

Full text
Abstract:
In the group of patients with typical clinical signs of acute tick-borne rickettsioses, specific IgM and/or IgG with/without IgA were found in 75.6% cases. IgG were low avidity in most cases, which indicated the recent primary infection. More than 20% of sera have single group specific IgA. In patients with atypical manifestations highly avidity IgG were predominant, that along with the presence of IgM and/or IgA may indicate re-infection or infection by new species, which is different from previous pathogen of the tick-borne spotted group rickettsioses.
APA, Harvard, Vancouver, ISO, and other styles
2

Novikova, L. I., S. S. Bochkareva, A. V. Aleshkin, S. IU Kombarova, O. E. Karpov, A. A. Pulin, O. A. Orlova, IU S. Lebedin, A. M. Vorobev, and E. R. Mekhtiev. "DYNAMICS OF ANTIBODIES TO VARIOUS ANTIGENS OF THE SARS-COV-2 CORONAVIRUS IN PATIENTS WITH CONFIRMED COVID-19 INFECTION." In Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-159.

Full text
Abstract:
Presence of IgG and IgM antibodies in venous blood of 76 patients with confirmed presence of SARS-CoV-2 was determined. The study was carried out by ELISA using Russian test systems. Revealed different levels of IgM antibodies to N-protein and RBD (receptor binding domain of the Spike protein). The level of IgM to RBD did not reach high values, while the level of IgM to N-protein sharply increased in a short period of time to high values by the 3rd week of the disease and decreased only by the 8th week. The dynamics of IgG antibodies to the whole virion antigen and the recombinant spikes was similar, reaching high values at 4-5 weeks of the disease, however, the dynamics of IgG to the N-protein differed, showing a slight increase by the 1st week of the disease and a low level throughout the entire period of observation. Different dynamics of production of IgG and IgM antibodies to N-protein and RBD were noted. The amount of IgM to the N-protein increased sharply and reached a high level, while the amount of IgG increased smoothly and did not show a high level. The opposite picture was observed for antibodies to RBD. The characteristic dynamics of IgG, measured using test systems withsorbed whole virion or recombinant spike proteins, suggests duration of the disease
APA, Harvard, Vancouver, ISO, and other styles
3

Cunningham-Rundles, C., J. Bussel, and A. Lipscombs. "CHANGES IN ANTI-CARD10LIPIN ANTIBODY TITER IN SERA OF I TP PATIENTS AFTER TREATMENT WITH INTRAVENOUS IMMUNOGLOBULIN." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643924.

Full text
Abstract:
Antibodies to cardiolipin have previously been demonstrated in the sera of patients with idiopathic thrombocytopenia purpura (ITP). We questioned whether the levels of anti-cardiolipin in the sera of patients with ITP would be altered after treatment with intravenous immunoglobulin (IVGG). Using flexible polyvinyl chloride microtiter plates coated with bovine cardiolipin, we measured IgG and IgM anti-cardio1ipin levels by ELISA before and at multiple intervals during and after IVGG treatment for 17 patients who had ITP. We found that within 7-10 days of treatment, 16 of 17 patients had further increases of IgG anti-cardiolipin antibody. This is probably due to the infusion of IVGG concentrates, which we found contained substantial amounts of IgG anti-cardio1ipin. Increases in platelet counts had significant correlation with increased IgG anti-cardio1ipin (p>0.01), presumably also due to the infusion of IVGG. Surprisingly, 16 of 17 patients had a marked increase in serum levels of IgM anti-cardiolipin 7-10 days post IVGG treatment. Since IVGG does not contain IgM anti-cardiolipin and our assay is specific for this isotype, this antibody represents de novo synthesis. We previously reported and have also confirmed here, that 16 of these 17 patients had increased serum IgM levels after IVGG treatment. The increase in serum IgM anti-cardio1ipin antibody may explain part of the increased total serum IgM observed. IVGG has been believed to be potentially suppressive of various immunologic activities; our data shows that immunologic stimulation also occurs. The biologic effect of increased serum IgG and IgM anti-cardiol ipin after IVGG treatment in ITP, particularly since cardiolipin may be a constituent of platelet membranes, is still uncertain.
APA, Harvard, Vancouver, ISO, and other styles
4

Triplett, D. A., J. T. Brant, K. Musgrave, and C. A. Orr. "RELATIONSHIP BETWEEN LUPUS ANTICOAGULANTS AND ANTIBODIES TO PHOSPHOLIPID." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643657.

Full text
Abstract:
The relationship of lupus anticoagulants (LA's) to antibodies (IgG and IgM) to cardiolipin (CL), phosphatidylserine (PS), phosphatidylinositol (PI) and phosphatidic acid (PA), detected by an enzyme linked immunoassay, was examined in a series of 100 patients with well characterized LA's. 73% of patients demonstrated antibodies to one or more phospholipids; 62% were positive for CL, 57% were positive for PS, 57% were positive for PI, and 51% were positive for PA. Of the samples with antibodies to phospholipid, 32% had IgG type antibody only, 16% had IgMonly, and 52% had both IgG and IgM antibodies. Of the 100 patients,19% had a history of thrombosis, 8% had ahistory of spontaneous abortion, and 6% had a history of seizure disorder. These complications occurred in the presence (61%) and absence (39%) of detectable phospholipid antibodies. Drug-related LA's were observed in 34 patients; of these 74% were positivefor antiphospholipid antibodies and 24% hada history of thrombosis.The distribution of antibody types with drug-related LA's was similarto the overall group, with 40% IgG only, 8%IgM only and 52% both IgG and IgM These findings indicate that IgG and IgM antibodies to phospholipid are not observed in all patients with lupus anticoagulants, that thrombosis does occur in this population in the absence of detectable antibodies to phospholipid and that drug-related LA's are associated with thrombosis. Furthermore, there appeared to be little relationship between the degree of prolongation of the aPTT and the titer of anti-phospholipid antibody.
APA, Harvard, Vancouver, ISO, and other styles
5

Pedrosa, Lara Alípio, ARIANA LACERDA GARCIA, and BEATRIZ RIBEIRO COUTINHO DE MENDONÇA FURTADO. "OS BENEFÍCIOS DO ALEITAMENTO MATERNO NO SISTEMA IMUNOLÓGICO." In II Congresso Brasileiro de Imunologia On-line. Revista Multidisciplinar em Saúde, 2022. http://dx.doi.org/10.51161/ii-conbrai/6018.

Full text
Abstract:
Introdução: A Organização Mundial de Saúde (OMS), o Fundo das Nações Unidas para a Infância (UNICEF) e o Ministério da Saúde (MS) preconizam o aleitamento materno exclusivo até os seis meses de idade. Ao nascimento, a criança apresenta baixos níveis de imunoglobulinas (IgM, IgA e IgE). No entanto, o leite materno apresenta uma importante função na transferência de imunidade passiva no período pós-natal, pois possui funções antimicrobianas, anti-inflamatórias e imunorreguladoras. Nos primeiros três anos de vida, o .aleitamento materno exerce efeito benéfico sobre a incidência de eczema, alergia alimentar, sensibilização atópica e “doença sibilante”. Objetivo: Destacar a importância do aleitamento materno e os seus benefícios no sistema imunológico do recém-nascido. Metodologia: Esta revisão bibliográfica trata-se de um estudo qualitativo de artigos seletivos publicados em sites específicos, como BVS, Scielo e Pubmed, acerca da reflexão do impacto imunológico benéfico pelo aleitamento materno. Resultados: : O aleitamento materno protege o lactente de infecções principalmente por meio dos anticorpos IgA secretores (IgAS), além de fatores bioativos. A proteção contra infecções tem sido bem evidenciada durante a lactação, combatendo infecções do trato respiratório, incluindo otite média, infecção do trato urinário, sepse neonatal e enterocolite necrosante, diarreia aguda e prolongada, ganhando relação com o sistema imunológico do lactente pelas propriedades do leite materno, que, em especial o colostro, apresenta elevadas concentrações de anticorpos (IgA, IgM, IgE e IgD), sendo um reforço natural imunológico de destaque. Outra característica imunizante do leite materno é a presença de células polimorfonucleares (macrófagos, neutrófilos e eosinófilos) que fagocitam microrganismos patogênicos. Há ainda a presença de substâncias com propriedades probióticas e antibióticas como a lisozima, lactoferrina e o fator bífido que combatem a instalação de agentes envolvidos na etiologia de doenças diarreicas. Conclusão: Entende-se, portanto, a necessidade de se estimular o aleitamento materno durante o primeiro semestre de vida, período em que a produção própria de IgA secretória é ainda pouco significativa. O baixo teor de alérgenos no leite materno, bem como as propriedades anti-inflamatórias e imunomoduladoras, devem prevenir alergias e promover o desenvolvimento de tolerância.
APA, Harvard, Vancouver, ISO, and other styles
6

Criel, A., B. Gilbert, A. Van Hoof, M. Hidajat, and A. Louwagie. "COMPARISION OF THE DETECTION OF LUPUS ANTICOAGULANTS USING THREE DIFFERENT METHODS AND THE PRESENCE OF ANTI-CARDIOLIPIN ANTIBODIES." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644233.

Full text
Abstract:
Lupus anticoagulant (LAC) is an antibody directed against phospholipids which prolongs in vitro clotting assays. Several detection methods have been described; however all give some different results. Recently ELISA and RIA assays have been developed which detect IgG and IgM anti-cardiolipin antibodies. The aim of our study was to compare three different LAC tests with an ELISA anti-cardiolipin test. The tests used were : kaolin clotting time (KCT or Exnertest), tissue thromboplastin inhibition test (TTI or Schleider test), activated partial thromboplastin time using a 50, 100, 200 fold dilution of the phospholipid preparation (APTT dilution test), and an IgG and IgM anti-cardiolipin ELISA test. 114 samples of patients suffering from diseases known to be accompanied with LAC antibodies (auto-immune diseases, recurrent abortion, thromboembolism, etc.) were studied. Positivity with one of the tests was found in 45 patients (39%). Patients with the diagnosis of SLE or otherimmune diseases showed the highest positivity (56%) whereas those with thromboembolism, recurrent abortion etc. were only positive in 27%.Among these 45 positive patients the TTI was positive in 41 cases (91 %);however in 10 cases (24 %) this was the only positivity found. The KCT test and the APTT dilution test were both positive in 18 cases (40 %). Anti-cardiolipin antibodies were found in 21 patients (47 %): IgG only in 12 (27 %), IgM only in 5 (11 %), both IgG and IgM in 2 (4 %); in 19 of these 21 patientsthe TTI was also positive.In our study the TTI test seems to be the most sensitive test but possibly also the test with the highest aspecific positivities. IgG and IgM anti-cardiolipin antibodies were less frequently found than expected.
APA, Harvard, Vancouver, ISO, and other styles
7

Maślińska, Maria, Joanna Dmowska-Chalaba, Małgorzata Mańczak, Long Shen, Lakshmanan Suresh, and Brygida Kwiatkowska. "FRI0245 RHEUMATOID FACTOR IN IGA, IGG AND IGM IMMUNOGLOBULIN CLASES IN PRIMARY SJöGREN’S SYNDROME." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.6365.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kunhipurayil, Hasna, Muna Ahmed, and Gheyath Nasrallah. "West Nile Virus Seroprevalence among Qatari and Immigrant Populations within Qatar." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0197.

Full text
Abstract:
Background: West Nile virus (WNV) is one of the most widely spread arboviruses worldwide and a highly significant pathogen in humans and animals. Despite frequent outbreaks and endemic transmission being reported in the Middle East and North Africa (MENA), seroprevalence studies of WNV in Qatar are highly lacking. Aim: This study aims to investigate the actual prevalence of WNV among local and expatriate communities in the Qatar using a large sample size of seemingly healthy donors. Method: A total of 1992 serum samples were collected from donors of age 18 or older and were tested for the presence of WNV antibodies. Serion enzyme-linked immunosorbent assay (ELISA) commercial microplate kits were used to detect the presence of the WNV IgM and IgG. The seropositivity was statistically analyzed using SPSS software with a confidence interval of 95%. Results: The seroprevalence of anti-WNV IgG and IgM in Qatar was 10.3% and 3.4%, respectively. The country-specific seroprevalence according to nationality for WNV IgG and IgM, respectively, were Sudan (37.0%, 10.0%), Egypt (31.6%, 4.4%), India (13.4%, 3.2%), Yemen(10.2%, 7.0%), Pakistan (8.6%, 2.7%), Iran (10.6%, 0.0%), Philippines (5.4%, 0.0%), Jordan(6.8%, 1.1%), Syria (2.6%, 9.6%), Palestine (2.6%, 0.6%), Qatar (1.6%, 1.7%), and Lebanon (0.9%, 0.0%). The prevalence of both IgM and IgG was significantly correlated with the nationality (p≤0.001). Conclusion: Among these tested nationalities, Qatar national has a relatively low burden of WNV disease. The highest prevalence of WNV was found in the Sub Saharan African nationalities like Sudan and Egypt. The seroprevalence of WNV is different from the previously reported arboviruses such as CHIKV and DENV, which was highest among Asian countries (India and Philippines). Further confirmatory tests such as viral neutralization assays are needed to confirm the IgM seropositivity in these samples since these samples could be a source of viral transmission through blood donation.
APA, Harvard, Vancouver, ISO, and other styles
9

Harris, EN, RA Asherson, E. Baguley, M. Ridley, and GRV Hughes. "A STANDARD ANTI-CARDIOLIPIN (aCL) TEST: USEFULNESS IN IDENTIFICATION OF THE ANTI-PHOSPHOLIPID SYNDROME." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644235.

Full text
Abstract:
Some, but not all, patients with the lupus anticoagulant and anti-cardiolipin antibodies are prone to thrombosis, fetal loss and thrombocytopenia. It will be important to identify the particular sub-group of patients with anti-phospholipid (aPL) antibodies most subject to these clinical disorders. A preliminary study has shown that the level of IgG aCL antibody is predicitive for thrombosis, fetal loss, and thrombocytopenia but it will be difficult to substantiate (or refute) these findings unless there is a uniform system to measure aCL antibody levels.Five test sera with defined IgG and IgM aCL levels are currently available to laboratories wishing to standardise the aCL test. The concentrations of aCL in these sera cover the full sensitive range of aCL solid phase assays. Using these. 5 test sera to calibrate our assay system, sera from 3000 patients were analysed: 1400 healthy adults and 1600 consecutive patients with autoimmune disorders. All sera from healthy adults had aCL levels below 10GPL (IgG aCL) or below 10MPL (IgM aCL) units. Of the 1600 autoimmune patients, 115 had levels above 5 GPL and/ or 5MPL units. More than 2/3 of patients with IgG aCL levels above 20 GPL units (30 patients) had thrombosis or fetal loss, but the frequency of these disorders decreased in the 10-20 GPL and 5-10 GPL unit groups. Of the 9 patients with IgM aCL levels above 15 MPL units, 6 had thrombosis or fetal loss.The availability of reference sera to measure IgG and IgM aCL antibody levels may better enable multicenter studies to be performed. A relatively uniform system of measurement may also enable easier identification and management of patients with the anti-phospholipid syndrome.
APA, Harvard, Vancouver, ISO, and other styles
10

De Oliveira, Laríssa Santos De Oliveira, Bianca Caroline Ferreira, and Adriana Piccinin. "PROPRIEDADES IMUNIZANTES DO LEITE MATERNO E SEUS BENEFÍCIOS NA PREVENÇÃO DE DOENÇAS ALÉRGICAS." In I Congresso Brasileiro de Imunologia On-line. Revista Multidisciplinar em Saúde, 2021. http://dx.doi.org/10.51161/rems/942.

Full text
Abstract:
Introdução: O termo “alergia” foi criado pelo pediatra australiano Clemens von Pirquet no começo do século XX. A definição sofreu modificações ao longo dos anos e hoje é interpretada como uma alteração do sistema imunológico levando a hipersensibilidade sintomática. Dessa maneira, uma alergia envolve uma resposta imunológica contra determinados antígenos presentes no meio ambiente. Essa resposta é o resultado de uma produção exagerada de IgE específico para esse alérgeno. Ao nascimento a criança apresenta baixos níveis de imunoglobulinas (IgM, IgA e IgE). No entanto, o leite materno apresenta uma importante função na transferência de imunidade passiva no período pós-natal, pois possui funções antimicrobianas, anti-inflamatórias e imunorreguladoras. Objetivo: Destacar a importância do aleitamento materno e os seus benefícios no sistema imunológico do recém-nascido contra alergias. Material e método: Este estudo trata-se de uma revisão bibliográfica e as bases de dados utilizadas foram Scielo e PubMed. Resultados: A Organização Mundial de Saúde (OMS), o Fundo das Nações Unidas para a Infância (UNICEF) e o Ministério da Saúde (MS) preconizam o aleitamento materno exclusivo até os seis meses de idade. Após esse período a recomendação é que recebam alimentos complementares, mas continuem com o aleitamento até dois anos. Trabalhos relatam que nos primeiros três anos de vida, o aleitamento natural exerce efeito benéfico sobre a incidência de eczema, alergia alimentar, sensibilização atópica e “doença sibilante”. No contexto da imunologia e da fisiologia, os discursos que respaldam as propriedades benéficas do leite materno, afirmam que este, especialmente o colostro, apresenta elevadas concentrações de anticorpos (IgA, IgM, IgE e IgD). Outra característica imunizante do leite materno é a presença de células polimorfonucleares (macrófagos, neutrófilos e eosinófilos) que fagocitam microrganismos patogênicos. Há ainda a presença de substâncias com propriedades probióticas e antibióticas como a lisozima, lactoferrina e o fator bífido que combatem a instalação de agentes envolvidos na etiologia de doenças diarreicas. Conclusão: O baixo teor de alérgenos no leite materno, bem como as propriedades anti-inflamatórias e imunomoduladoras, devem prevenir alergias e promover o desenvolvimento de tolerância. Além disso, sabe-se que as crianças amamentadas ficam menos doentes, necessitando menos de atendimento médico, hospitalizações e medicamentos.
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "IgM"

1

da Rosa, Maria Inês. Accuracy of rapid IgM and IgG Antibody Test for SARS-CoV-2 Infection Diagnosis: a systematic review and meta analysis. INPLASY - International Platform of Registered Systematic Review Protocols, April 2020. http://dx.doi.org/10.37766/inplasy2020.4.0099.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mackey, Katherine, Irina Arkhipova-Jenkins, Charlotte Armstrong, Emily Gean, Johanna Anderson, Robin A. Paynter, and Mark Helfand. Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Rapid Living Review. Agency for Healthcare Research and Quality (AHRQ), March 2021. http://dx.doi.org/10.23970/ahrqepccovidimmunity.

Full text
Abstract:
 Evidence suggests that the majority of adults develop detectable levels of immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies following infection with SARS-CoV-2 (moderate strength of evidence* [SoE]).  IgM levels peak approximately 20 days after symptom onset or RT-PCR diagnosis and subsequently decline. IgG levels peak approximately 25 days after symptom onset or RT-PCR diagnosis and may remain detectable for at least 120 days (moderate SoE*).  Almost all adults develop neutralizing antibodies in response to SARS-CoV-2 infection, and these antibodies may remain detectable for at least 152 days (low SoE*).  A small percentage of people do not develop antibodies in response to SARS-CoV-2 infection for reasons that are largely unclear but may be related to less severe disease or absence of symptoms.  Antibody prevalence does not appear to vary by age or sex, but older age may be associated with higher antibody levels (low SoE*). Non-White race may be associated with higher antibody prevalence and levels (low SoE*). COVID-19 severity and presence of symptoms may also be associated with higher antibody prevalence or levels (low SoE*). More evidence is needed to draw stronger conclusions regarding how the antibody response varies by patient characteristics and disease factors.  Studies to date have not established the relationship between the development of antibodies after RT-PCR-diagnosed SARS-CoV-2 infection and the risk of reinfection. Studies based on index serologic testing suggest that the presence of antibodies is associated with a lower risk of a subsequent positive SARS-CoV-2 RT-PCR test.
APA, Harvard, Vancouver, ISO, and other styles
3

Jork, M., A. Atlas, and L. Fang. LDP IGP Synchronization. RFC Editor, March 2009. http://dx.doi.org/10.17487/rfc5443.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Marshak, David. IBM WebSphere Portal. Boston, MA: Patricia Seybold Group, February 2003. http://dx.doi.org/10.1571/pr2-13-03cc.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Seybold, Patricia. IBM Acquires Venetica. Boston, MA: Patricia Seybold Group, September 2004. http://dx.doi.org/10.1571/psgp9-17-04cc.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Pedemonte, E. IGD 04741.R1.0. Office of Scientific and Technical Information (OSTI), September 2022. http://dx.doi.org/10.2172/1890835.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Spartz, R. IGD 00951.R3.10. Office of Scientific and Technical Information (OSTI), September 2022. http://dx.doi.org/10.2172/1890833.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hegde, S., C. Filsfils, K. Talaulikar, and A. Gulko. IGP Flexible Algorithm. Edited by P. Psenak. RFC Editor, February 2023. http://dx.doi.org/10.17487/rfc9350.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Yordanov, Daniel, Lyudmila Boyanova, Rumyana Markovska, Petyo Hadzhiyski, Galina Gergova, and Ivan Mitov. Seroprevalence of Helicobacter pylori IgG and CagA IgG in Bulgarian Children. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, August 2018. http://dx.doi.org/10.7546/crabs.2018.08.15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Pingel, L. A. IXM gas sampling procedure. Office of Scientific and Technical Information (OSTI), March 1995. http://dx.doi.org/10.2172/34200.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography